Holt Peter R, Bresalier Robert S, Ma Chan K, Liu Kai-Feng, Lipkin Martin, Byrd James C, Yang Kan
Department of Medicine, St. Luke's/Roosevelt Hospital Center, Columbia University, New York, New York, USA.
Cancer. 2006 Jan 15;106(2):287-96. doi: 10.1002/cncr.21618.
Calcium and vitamin D are chemopreventive agents for colorectal neoplasia. Studies of the effects of calcium and vitamin D on early surrogate markers of reduced risk, such as proliferation, have been limited to evaluation of the flat colorectal mucosa. Biologic changes that may occur in colorectal adenomas after chemopreventive regimens have not been reported.
In the current study, adenomatous polyps were transected, approximately 50% were removed for histologic examination, and the remnants tattooed before the administration of either calcium carbonate (1500 mg 3 times daily) plus vitamin D(3) 400 IU or a placebo for 6 months. At study end, polyp remnants were resected completely and were used for histologic examination. Immunohistochemical staining was performed in both flat mucosa and in polyp tissue. Proliferation was assessed by MIB-1 staining; apoptosis was assessed by terminal deoxyuridine triphosphate-biotin nick-end labeling, BAK, and Bcl-2 staining; and cytokeratin AE1, vitamin D receptor, MUC5AC mucin, and galectin-3 were assessed by immunohistochemistry.
Nineteen patients, including 11 patients in the treatment group and 8 patients in the control group, completed the study. Proliferative indices fell both in flat mucosa and in polyps in the treatment group, and there were no significant changes in the control group. Apoptosis and Bcl-2 immunostaining were unchanged in both groups, but the frequency of BAK-immunostained cells in the interior of polyps rose significantly. Vitamin D receptor staining increased slightly and significantly in flat rectal tissue in the treatment group. There were no significant changes in galectin-3 staining, but a striking reduction in MUC5AC mucin staining in polyps was observed after treatment with calcium plus vitamin D.
The administration of a calcium plus vitamin D chemopreventive regimen resulted in several changes in adenomatous tissue that may have contributed to reduced polyp formation.
钙和维生素D是结直肠肿瘤的化学预防剂。钙和维生素D对降低风险的早期替代标志物(如增殖)影响的研究仅限于对平坦结直肠黏膜的评估。化学预防方案后结直肠腺瘤可能发生的生物学变化尚未见报道。
在本研究中,将腺瘤性息肉横切,约50%切除用于组织学检查,残余部分在给予碳酸钙(每日3次,每次1500毫克)加维生素D3 400国际单位或安慰剂6个月前进行标记。研究结束时,将息肉残余部分完全切除并用于组织学检查。在平坦黏膜和息肉组织中均进行免疫组织化学染色。通过MIB-1染色评估增殖;通过末端脱氧尿苷三磷酸-生物素缺口末端标记、BAK和Bcl-2染色评估凋亡;通过免疫组织化学评估细胞角蛋白AE1、维生素D受体、MUC5AC黏蛋白和半乳糖凝集素-3。
19例患者完成了研究,其中治疗组11例,对照组8例。治疗组平坦黏膜和息肉中的增殖指数均下降,而对照组无显著变化。两组的凋亡和Bcl-2免疫染色均无变化,但息肉内部BAK免疫染色细胞的频率显著升高。治疗组平坦直肠组织中维生素D受体染色略有显著增加。半乳糖凝集素-3染色无显著变化,但钙加维生素D治疗后息肉中MUC5AC黏蛋白染色显著减少。
给予钙加维生素D化学预防方案导致腺瘤组织发生了一些变化,这些变化可能有助于减少息肉形成。